HAVCR1 and prostate carcinoma: This showed an increase in HAVcR1 gene expression in primary tumours; however, significance was not reached (p = 0.185), Figure 1D. The conclusion was that whilst HAVcR-1 expression was increased with prostate cancer progression, the shedding of the ectodomain was reduced, indicating that an unknown mechanism was involved in preventing shedding.